DATA
VISIT DATA
Here are the gold-standard databases and data visualizations of R&D funding, approved products and candidates in the pipeline for neglected diseases, emerging infectious diseases and maternal health.
G-FINDER
G-FINDER
The annual tracker of R&D investment into new drugs, vaccines, diagnostics and vector control products for global health.
Infectious Disease R&D Tracker
Approved products and technologies, as well as candidates in the development pipeline, for global health priorities.
Maternal Health Pipeline
Database profiling medicines, diagnostics, and devices for seven significant pregnancy-related conditions.
Snakebite Envenoming Medicines Database
Database of all snakebite envenoming medicines with direct action on toxins.
INSIGHTS
VISIT INSIGHTS
Here you will find the analysis and insights to support decisions - whether you're funding research, setting policies, developing products or advocating for change.
Explore our hubs
The Investment Landscape Hub
A unique source of data and analysis tracking the funding of global health R&D and the pipeline of products in development. Powered by G-FINDER.
The Impact of Global Health R&D Hub
Milestone analyses of the health and economic impact of the last two decades of investment in global health R&D.
Women's Health Hub
This resource hub provides a suite of data, insights and tools to accelerate progress in women’s health R&D
Report Library
Our reports deliver critical insights using the evidence collected through G-FINDER and over two decades of independent analysis.
Health areas
This quick reference guide gives you a snapshot analysis of the R&D needs and the state of innovation to tackle each disease or condition we cover. It's a handy quick overview of what's needed to impact global health in these areas.
Hubs
Themed collections of all the data, analysis and tools you need to understand the landscape and make smart decisions on global health R&D.
TOOLS
VISIT TOOLS
We've created some practical frameworks and tools you can use to assess and increase impact in global health.
Comms & press kits
Join us in creating global health impact for the world's neglected diseases and conditions with our communications resources and tools.
Impact Framework
A global network of experts collaborated for two years to develop this comprehensive set of metrics that create an impact assessment framework for global health R&D.
100 Days Mission Scorecard
Is the world ready to deploy a new product to tackle an epidemic within 100 days of an outbreak?
ABOUT US
VISIT ABOUT US
Meet the team working to create a more equitable future through global health innovation and impact.
Our team
Meet our diverse international team of experts, who collate and analyse data on global health funding and the innovation pipeline
Join Us
We build bridges, partnerships and consensus across the complex ecosystem of global health R&D players. Find out how to partner with us, commission our expertise, and how to join our team when we have vacancies.
Contact Us
Please get in touch with any questions or feedback. Between us, we cover most time zones so one of us will get back to you quickly.
NEWS

Research Assistant

Indra Rudiansyah

Indonesia

Education

About

Bachelor of Science (Microbiology); Master of Science (Biotechnology; D.Phil. in Clinical Medicine.

Indra obtained his D.Phil. in clinical medicine from the University of Oxford, specializing in vaccine development against malaria (P. falciparum). With a robust scientific background and extensive experience in the vaccine industry, he played a pivotal role in the clinical advancement of the ChAdOx1-nCOV19 vaccine, developed jointly by the University of Oxford and AstraZeneca during the COVID-19 pandemic.

Moreover, he contributed significantly to the Office of COVAX Facility, offering support to vaccine and technical policy teams, as well as the Independent Product Group Secretariat (IPG), in monitoring the landscape of COVID-19 vaccine development, vaccination strategy, and its implications for the COVAX portfolio.

Before joining PCR, he spearheaded the mRNA vaccine program at Bio Farma Indonesia in collaboration with organizations such as WHO, the Medicine Patent Pool (MPP), and the Coalition for Epidemic Preparedness Innovations (CEPI). Indra’s overarching objective is to enhance global health equity by harnessing cutting-edge technology in pharmaceutical research and development.

Share

Harriet Bell